CDH1 and neoplasm: Phenotyping these tumor cells identified a subpopulation of CD29+ and E-cadherin-expressing (CD29+E-cad+) cells enriched for cell surface antigenic markers of primitive cell phenotypes, namely CD24 and CD133 (CD24highCD133+E-cad+; Fig. 5b).